
Sign up to save your podcasts
Or


Send us a text
Roger Green conducts one-on-one interviews with Stephen Harrison and Alina Allen to explore specific issues regarding new issues and insights for clinical research and drug development resulting from the work of Dr. Allen and her colleagues.
Stephen Harrison discusses the important contribution this paper makes to our knowledge about disease progression. He then suggests several types of studies and issues that are likely to progress from this research and closes by focusing on its immense value for cirrhotic patients and medications. Alina Allen discusses her vision of how both research and treatment might evolve as researchers learn more about the interplay of different types of diagnostic testing in both research and clinical settings.
By SurfingNASH.com3.9
2424 ratings
Send us a text
Roger Green conducts one-on-one interviews with Stephen Harrison and Alina Allen to explore specific issues regarding new issues and insights for clinical research and drug development resulting from the work of Dr. Allen and her colleagues.
Stephen Harrison discusses the important contribution this paper makes to our knowledge about disease progression. He then suggests several types of studies and issues that are likely to progress from this research and closes by focusing on its immense value for cirrhotic patients and medications. Alina Allen discusses her vision of how both research and treatment might evolve as researchers learn more about the interplay of different types of diagnostic testing in both research and clinical settings.

32,252 Listeners

30,719 Listeners

9,748 Listeners

104 Listeners

21,144 Listeners

3,378 Listeners

113,257 Listeners

56,892 Listeners

9,559 Listeners

8,071 Listeners

10,205 Listeners

6,450 Listeners

0 Listeners

419 Listeners

684 Listeners